Abstract
An increased risk for depression has been found in multiple sclerosis (MS). The purpose of the present study has been to give suggestions to guidelines for diagnosis and treatment of depression in MS in Denmark based on the international literature and recommendations. The method was a review of the relevant literature. The study recommends assessment of all MS patients for depression. Treatment of depression with serotonin reuptake inhibitors and/or cognitive behavioural therapy is recommended, depending on the severity of the illness. Caution is recommended in patients receiving beta interferon treatment.
MeSH terms
-
Bipolar Disorder / drug therapy
-
Bipolar Disorder / etiology
-
Depression / diagnosis
-
Depression / drug therapy
-
Depression / etiology*
-
Depressive Disorder / diagnosis
-
Depressive Disorder / drug therapy
-
Depressive Disorder / etiology*
-
Humans
-
Immunologic Factors / adverse effects
-
Immunologic Factors / therapeutic use
-
Interferon-beta / adverse effects
-
Interferon-beta / therapeutic use
-
Multiple Sclerosis / complications*
-
Multiple Sclerosis / drug therapy
-
Multiple Sclerosis / psychology
-
Practice Guidelines as Topic
-
Risk Factors
-
Selective Serotonin Reuptake Inhibitors / therapeutic use
Substances
-
Immunologic Factors
-
Serotonin Uptake Inhibitors
-
Interferon-beta